Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fargo, North Dakota 58104


Purpose:

This is a single-center, randomized, open-label, multi-dose crossover study assessing the pharmacokinetic profiles of diazoxide choline coated versus uncoated formulations in healthy volunteers. The primary objective is to compare the pharmacokinetic (PK) profiles of diazoxide choline controlled-release coated tablets versus uncoated tablets in healthy volunteers under fed conditions. Secondary objectives are to assess diazoxide choline pharmacokinetic (PK) parameters under fasted conditions, and to assess the safety and tolerability of diazoxide choline controlled-release coated tablets versus uncoated tablets in healthy volunteers.


Criteria:

Inclusion Criteria: - Signed informed consent - Healthy male and female subjects 18 to 75 years of age - Body mass index (BMI) between 22-35 kg/m2 - Fasting glucose ≤ 125 mg/dL and HbA1C ≤ 6.5. - Fasting triglyceride ≥100 mg/dL and ≤ 500 mg/dL - Not pregnant Exclusion Criteria: - Significant underlying medical conditions - Clinical laboratory test values outside the accepted range - Smokers, tobacco users, or subjects currently using nicotine products - Substance abuse - History of allergic response(s) to diazoxide or related drugs - Recent significant weight loss - Use of medication affecting body weight, lipid or glucose metabolism - Unable to comply with study procedures


NCT ID:

NCT00688857


Primary Contact:

Principal Investigator
Alan K. Copa, Pharm. D.
PRACS Institute, Ltd. - Cetero Research


Backup Contact:

N/A


Location Contact:

Fargo, North Dakota 58104
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.